Lipodystrophy papers of the month

NOVEMBER 2024

https://pubmed.ncbi.nlm.nih.gov/39484826/

OCTOBER 2024

https://pubmed.ncbi.nlm.nih.gov/39490439/

AUGUST 2024

Lipodystrophic laminopathies: from Dunnigan disease to progeroid syndromes
Díaz-López et al.
International Journal of Molecular Sciences
DOI: 10.3390/ijms25179324
https://pubmed.ncbi.nlm.nih.gov/39273270/

A cohort analysis of familial partial lipodystrophy from two Mediterranean countries
Fernández-Pombo et al.
Diabetes Obes Metab
DOI: 10.1111/dom.15882
https://pubmed.ncbi.nlm.nih.gov/39171574/

Loss of HD-PTP function results in lipodystrophy, defective cellular signaling, and altered lipid homeostasis
Schultz et al.
J Cell Sci
DOI: 10.1242/jcs.262032
https://pubmed.ncbi.nlm.nih.gov/39155850/

Cxcr4 regulates a pool of adipocyte progenitors and contributes to adiposity in a sex-dependent manner
Steiner et al.
Nat Commun
DOI: 10.1038/s41467-024-50985-8
https://pubmed.ncbi.nlm.nih.gov/39103342/

JULY 2024

Case report: First Chinese patient with family partial lipodystrophy type 6 due to novel compound heterozygous mutations in the LIPE gene
Zhou et al.
Front Genet
DOI: 10.3389/fgene.2024.1417613
https://pubmed.ncbi.nlm.nih.gov/39113684/

Preclinical evaluation of tissue-selective gene therapies for congenital generalised lipodystrophy
Tiwari et al.
Gene Ther
DOI: 10.1038/s41434-024-00471-z
https://pubmed.ncbi.nlm.nih.gov/39069561/

Circulating exosomal circRNA-miRNA-mRNA network in a familial partial lipodystrophy type 3 family with a novel PPARG frameshift mutation c.418dup
Zhou et al.
Am J Physiol Endocrinol Metab
DOI: 10.1152/ajpendo.00094.2024
https://pubmed.ncbi.nlm.nih.gov/39017680/

Patni et al.
Orphanet J Rare Dis
DOI: 10.1186/s13023-024-03245-3
https://pubmed.ncbi.nlm.nih.gov/38992753/

Wang et al.
J Biol Chem
DOI: 10.1016/j.jbc.2024.107534
https://pubmed.ncbi.nlm.nih.gov/38981533/

Pannier et al.
Birth Defects Res
DOI: 10.1002/bdr2.2380
https://pubmed.ncbi.nlm.nih.gov/38980211/

PAQR4 regulates adipocyte function and systemic metabolic health by mediating ceramide levels
Zhu et al.
Nat Metab
DOI: 10.1038/s42255-024-01078-9
https://pubmed.ncbi.nlm.nih.gov/38961186/

Case report: two novel PPARG pathogenic variants associated with type 3 familial partial lipodystrophy in Brazil
Alvares da Silva et al.
Diabetol Metab Syndr
DOI: 10.1186/s13098-024-01387-9
https://pubmed.ncbi.nlm.nih.gov/38951919/

Progerin forms an abnormal meshwork and has a dominant-negative effect on the nuclear lamina
Kim et al.
Proc Natl Acad Sci U S A
DOI: 10.1073/pnas.2406946121
https://pubmed.ncbi.nlm.nih.gov/38917015/

Lipodystrophy prevalence, "Lipodystrophy-like phenotypes," and diagnostic challenges
Akinci et al.
Diabetes
DOI: 10.2337/dbi24-0018
https://pubmed.ncbi.nlm.nih.gov/38900954/

Agrawal et al.
Diabetes
DOI: 10.2337/db23-0575
https://pubmed.ncbi.nlm.nih.gov/38345889/

JUNE 2024

Identification of ibuprofen targeting CXCR family members to alleviate metabolic disturbance in lipodystrophy based on bioinformatics and in vivo experimental verification

Cao et al.
Front Endocrinol (Lausanne)
DOI: 10.3389/fendo.2024.1414908
https://pubmed.ncbi.nlm.nih.gov/38989000/

Foss-Freitas et al.
DOI: 10.1101/2024.06.24.24309093
PREPRINT medRxiv
https://pubmed.ncbi.nlm.nih.gov/38978649/

A rapid action plan to improve diagnosis and management of lipodystrophy syndromes
Front Endocrinol (Lausanne)
Fourman et al.
DOI: 10.3389/fendo.2024.1383318
https://pubmed.ncbi.nlm.nih.gov/38952397/

Hypertriglyceridemia results from an impaired catabolism of triglyceride-rich lipoproteins in PLIN1-related lipodystrophy
Vergès et al.
Arterioscler Thromb Vasc Biol
DOI: 10.1161/ATVBAHA.124.320774
https://pubmed.ncbi.nlm.nih.gov/38899472/

Comprehensive analysis of morbidity and mortality patterns in familial partial lipodystrophy patients: insights from a population study
Guidorizzi et al.
Front Endocrinol (Lausanne)
DOI: 10.3389/fendo.2024.1359211
https://pubmed.ncbi.nlm.nih.gov/38887266/

Hill et al.
Pediatr Dermatol
DOI: 10.1111/pde.15668
https://pubmed.ncbi.nlm.nih.gov/38887123/

Guo et al.
Pediatr Dermatol
DOI: 10.1111/pde.15667
https://pubmed.ncbi.nlm.nih.gov/38881047/

Nuclear lipid droplet: Guardian of nuclear membrane lipid homeostasis?
Fujimoto
Curr Opin Cell Biol
DOI: 10.1016/j.ceb.2024.102370
https://pubmed.ncbi.nlm.nih.gov/38744005/
 
Lipomatoses
Dupuis et al.
Ann Endocrinol (Paris)
DOI: 10.1016/j.ando.2024.05.003
https://pubmed.ncbi.nlm.nih.gov/38871514/
 
Immune checkpoint inhibitors-associated generalized lipodystrophy: reconstructive challenges of an emerging and distinct form of lipodystrophy
Kreutz-Rodrigues et al.
J Craniofac Surg
DOI: 10.1097/SCS.0000000000010409
https://pubmed.ncbi.nlm.nih.gov/38869298/

Seipin is involved in oxygen-glucose deprivation/reoxygenation induced neuroinflammation by regulating the TLR3/TRAF3/NF-κB pathway
Guo et al.
International Immunopharmacology
DOI: 10.1016/j.intimp.2024.112182
https://pubmed.ncbi.nlm.nih.gov/38703568/
 
ADH1B, the adipocyte-enriched alcohol dehydrogenase, plays an essential, cell-autonomous role in human adipogenesis
Gautheron et al.
Proc Natl Acad Sci U S A
DOI: 10.1073/pnas.2319301121
https://pubmed.ncbi.nlm.nih.gov/38838011/

Partial lipodystrophy: Clinical presentation and treatment
Mosbah et al.
Ann Endocrinol (Paris)
DOI: 10.1016/j.ando.2024.05.015
https://pubmed.ncbi.nlm.nih.gov/38871513/

Prieur
Ann Endocrinol (Paris)
DOI: 10.1016/j.ando.2024.05.017
https://pubmed.ncbi.nlm.nih.gov/38871503/
 
Primary disease of adipose tissue: When to think about and how to evaluate it in clinical practice?
Vatier et al.
Ann Endocrinol (Paris)
DOI: 10.1016/j.ando.2024.05.019
https://pubmed.ncbi.nlm.nih.gov/38871502/

Leptin replacement therapy in the management of lipodystrophy syndromes
Vigouroux et al.
Ann Endocrinol (Paris)
DOI: 10.1016/j.ando.2024.05.022
https://pubmed.ncbi.nlm.nih.gov/38871500/

PPA1 promotes adipogenesis by regulating the stability of C/EBPs
Wu et al.
Cell Death & Differentiation
DOI: 10.1038/s41418-024-01309-2
https://www.nature.com/articles/s41418-024-01309-2

Seipin deficiency-induced lipid dysregulation leads to hypomyelination-associated cognitive deficits via compromising oligodendrocyte precursor cell differentiation
Cui et al.
Cell Death & Differentiation
DOI: 10.1038/s41419-024-06737-z
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11109229/

OTULIN deficiency: focus on innate immune system impairment
Dou et al.
Front Immunol
DOI: 10.3389/fimmu.2024.1371564
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11106414/

A unifying mechanism for seipin-mediated lipid droplet formation
Klug et al.
FEBS Lett
DOI: 10.1002/1873-3468.14825
https://febs.onlinelibrary.wiley.com/doi/10.1002/1873-3468.14825

APRIL 2024 

GLP-1 receptor agonist improves metabolic disease in a pre-clinical model of lipodystrophy
Roumane et al.
Front Endocrinol (Lausanne)
DOI: 10.3389/fendo.2024.1379228
https://pubmed.ncbi.nlm.nih.gov/38745956/

A novel subtype of acquired generalized lipodystrophy associated with subcutaneous panniculitis-like T-cell lymphoma
Hoff et al.
JCEM Case Rep
DOI: 10.1210/jcemcr/luae069
https://pubmed.ncbi.nlm.nih.gov/38681964/

Diagnostic and referral pathways in patients with rare lipodystrophy and insulin-resistance syndromes: key milestones assessed from a national reference center
Donadille et al.
Orphanet J Rare Dis
DOI: 10.1186/s13023-024-03173-2
https://pubmed.ncbi.nlm.nih.gov/38678257/

Heterogeneity and high prevalence of bone manifestations, and bone mineral density in congenital generalized lipodystrophy subtypes 1 and 2
Freire et al.
Front Endocrinol (Lausanne)
DOI: 10.3389/fendo.2024.1326700
https://pubmed.ncbi.nlm.nih.gov/38633760/

Gestational and neonatal outcomes of women with partial Dunnigan lipodystrophy
Valerio et al.
Front Endocrinol (Lausanne)
DOI: 10.3389/fendo.2024.1359025
https://pubmed.ncbi.nlm.nih.gov/38633761/

Ip3r-Grp75-Vdac and relevant Ca2+ signaling regulate dietary palmitic acid-induced de novo lipogenesis by mitochondria-associated ER membrane (MAM) recruiting Seipin in yellow catfish
Song et al.
J Nutr
DOI: 10.1016/j.tjnut.2024.04.021
https://pubmed.ncbi.nlm.nih.gov/38641205/

Mesenchymal-specific Alms1 knockout in mice recapitulates metabolic features of Alström syndrome
McKay et al.
Mol Metab
DOI: 10.1016/j.molmet.2024.101933
https://pubmed.ncbi.nlm.nih.gov/38583571/
 
Loss-of-function variants affecting the STAGA complex component SUPT7L cause a developmental disorder with generalized lipodystrophy
Kopp et al.
Hum Genet
DOI: 10.1007/s00439-024-02669-y
https://pubmed.ncbi.nlm.nih.gov/38592547/

SIRT1 serum concentrations in lipodystrophic syndromes
Salvatori et al.
International Journal of Molecular Sciences
DOI: 10.3390/ijms25094785
https://pubmed.ncbi.nlm.nih.gov/38732001/

MARCH 2024

Regulated regeneration of adipose tissue in lipodystrophic Agpat2-null mice partially ameliorates hepatic steatosis
Agarwal et al.
iScience
DOI: 10.1016/j.isci.2024.109517
https://pubmed.ncbi.nlm.nih.gov/38623324/

Khan et al.
Mol Genet Genomic Med
DOI: 10.1002/mgg3.2274
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10958179/

Adipose transplantation improves metabolism and atherosclerosis but not PVAT abnormality or vascular dysfunction in lipodystrophic Seipin/Apoe null mice
Meng et al.
Am J Physiol Cell Physiol
DOI: 10.1152/ajpcell.00698.2023
https://pubmed.ncbi.nlm.nih.gov/38525541/

Case report: A novel splice-site mutation of MTX2 gene caused mandibuloacral dysplasia progeroid syndrome: the first report from China and literature review
Fu et al.
Front Endocrinol (Lausanne)
DOI: 10.3389/fendo.2024.1345067
https://pubmed.ncbi.nlm.nih.gov/38544690/
 
Clinicopathological characteristics, treatment and follow-up of lipodystrophia centrifugalis abdominalis infantilis: A retrospective case series in China
Zhao et al.
Australas J Dermatol
DOI: 10.1111/ajd.14203
https://pubmed.ncbi.nlm.nih.gov/38095123/

Mitophagy defect mediates the aging-associated hallmarks in Hutchinson-Gilford progeria syndrome
Sun et al.
Aging Cell
DOI: 10.1111/acel.14143
https://pubmed.ncbi.nlm.nih.gov/38482753/

Rare monogenic causes of steatotic liver disease masquerading as MASLD
Brouwers and Cassiman
J Hepatol
DOI: 10.1016/j.jhep.2024.02.025
https://pubmed.ncbi.nlm.nih.gov/38458321/

Analysis of disease characteristics of a large patient cohort with congenital generalized lipodystrophy from the Middle East and North Africa
Yaarubi et al.
Orphanet J Rare Dis
DOI: 10.1186/s13023-024-03084-2
https://pubmed.ncbi.nlm.nih.gov/38481246/

Kovalskaia et al.
Genes (Basel)
DOI: 10.3390/genes15020180
https://pubmed.ncbi.nlm.nih.gov/38397171/
 
SARS-CoV-2 infection alters the phenotype and gene expression of adipocytes
Quaranta et al.
Int J Mol Sci
DOI: 10.3390/ijms25042086
https://pubmed.ncbi.nlm.nih.gov/38396763/

Defining the progeria phenome
Worm et al.
Aging (Albany NY)
DOI: 10.18632/aging.205537
https://pubmed.ncbi.nlm.nih.gov/38345566/

Serum levels of adiponectin differentiate generalized lipodystrophies from anorexia nervosa
Ceccarini et al.
J Endocrinol Invest
DOI: 10.1007/s40618-024-02308-3
https://pubmed.ncbi.nlm.nih.gov/38358463/

The efficacy and safety of glucagon-like peptide-1 agonists in a retrospective study of patients with familial partial lipodystrophy
Foss-Freitas et al.
Diabetes Care
DOI: 10.2337/dc23-1614
https://pubmed.ncbi.nlm.nih.gov/38300898/

JANUARY 2024

Effect of β-estradiol on adipogenesis in a 3T3-L1 Cell model of prelamin A accumulation
Cobelo-Gómez et al.
Int. J. Mol. Sci.
DOI: 10.3390/ijms25021282
https://pubmed.ncbi.nlm.nih.gov/38279282/

Metabolic and other morbid complications in congenital generalized lipodystrophy type 4
Akinci et al.
Am. J. Med. Genet. A.
DOI: 10.1002/ajmg.a.63533
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11043304/

Familial screening for the prevention of rare diseases: A focus on lipodystrophy in Southern Saudi Arabia
Abuzenadah et al.
J. Epidemiol Glob. Health
DOI: 10.1007/s44197-023-00182-5
https://pubmed.ncbi.nlm.nih.gov/38234231/

Perilipin 1: a systematic review on its functions on lipid metabolism and atherosclerosis in mice and humans
Desgrouas et al.
Cardiovasc. Res.
DOI: 10.1093/cvr/cvae005
https://pubmed.ncbi.nlm.nih.gov/38214891/

Epidemiological characteristics of patients with Hutchinson-Gilford progeria syndrome and progeroid laminopathies in China
Wang et al.
Pediatr. Res.
DOI: 10.1038/s41390-023-02981-9
https://pubmed.ncbi.nlm.nih.gov/38191824/

Phospholipid biosynthetic pathways and lipodystrophies: a novel syndrome due to PLAAT3 deficiency
Agarwal and Garg
Nat. Rev. Endocrinol.
DOI: 10.1038/s41574-023-00950-0
https://pubmed.ncbi.nlm.nih.gov/38191657/

Impact of lipodystrophy on health-related quality of life: the QuaLip study
Demir et al.
Orphanet J. Rare Dis.
DOI: 10.1186/s13023-023-03004-w
https://pubmed.ncbi.nlm.nih.gov/38183080/

Molecular characterization of the grass carp Bscl2 gene and its expression response to lipid accumulation, nutritional status, insulin and glucagon
Yang et al.
Comp. Biochem. Physiol. B. Biochem. Mol. Biol.
DOI: 10.1016/j.cbpb.2023.110931
https://pubmed.ncbi.nlm.nih.gov/38070669/

Weng et al.
Nat. Commun.
DOI: 10.1038/s41467-023-44393-7
https://pubmed.ncbi.nlm.nih.gov/38168040/

DECEMBER 2023

Influence of diet and body weight in treatment-resistant acquired partial lipodystrophy after hematopoietic stem cell transplantation and its potential for metabolic improvement
Ishida et al.
Diabetol Int
DOI: 10.1007/s13340-023-00674-6
https://pubmed.ncbi.nlm.nih.gov/38524924/

Liver transplantation in patient with Berardinelli-Seip syndrome: A literature review and case report
Aliyev et al.
Pediatric Transplantation
DOI: 10.1111/petr.14680
https://pubmed.ncbi.nlm.nih.gov/38149359/

Molecular mechanisms of perilipin protein function in lipid droplet metabolism
Griseti et al.
FEBS Lett.
DOI: 10.1002/1873-3468.14792
https://pubmed.ncbi.nlm.nih.gov/38140813/

DNA repair-deficient premature aging models display accelerated epigenetic age
Perez et al.
Aging Cell
DOI: 10.1111/acel.14058
https://pubmed.ncbi.nlm.nih.gov/38140713/

Patients' perspective on the medical pathway from first symptoms to diagnosis in genetic lipodystrophy
Mosbah et al.
Eur J Endocrinol.
DOI: 10.1093/ejendo/lvad169
https://pubmed.ncbi.nlm.nih.gov/38128113/

Clinical characteristics of patients with acquired partial lipodystrophy: a multicenter retrospective study
Magno et al.
J Clin Endocrinol Metab.
DOI: 10.1210/clinem/dgad700
https://pubmed.ncbi.nlm.nih.gov/38061004/

The farnesyl transferase inhibitor (FTI) lonafarnib improves nuclear morphology in ZMPSTE24-deficient fibroblasts from patients with the progeroid disorder MAD-B
Odinammadu et al.
Nucleus
DOI: 10.1080/19491034.2023.2288476
https://pubmed.ncbi.nlm.nih.gov/38050983/

Preclinical, randomized phase 1, and compassionate use evaluation of REGN4461, a leptin receptor agonist antibody for leptin deficiency
Altarejos et al.
Sci Transl Med.
DOI: 10.1126/scitranslmed.add4897
https://pubmed.ncbi.nlm.nih.gov/37992152/

Clinical characterisation and comorbidities of acquired generalised lipodystrophy: A 14-year follow-up study
Fernández-Pombo et al.
J Clin Med.
DOI: 10.3390/jcm12237344
https://pubmed.ncbi.nlm.nih.gov/38068396/

Mineralcorticoid receptor antagonism prevents type 2 familial partial lipodystrophy brown adipocyte dysfunction
Schena et al.
Cells
DOI: 10.3390/cells12222586.
https://pubmed.ncbi.nlm.nih.gov/37998321/
 
Loss of phospholipase PLAAT3 causes a mixed lipodystrophic and neurological syndrome due to impaired PPARγ signaling
Schuermans et al.
Nat. Genet.
DOI: 10.1038/s41588-023-01535-3.
https://pubmed.ncbi.nlm.nih.gov/37919452/
 
Natural history and comorbidities of generalised and partial lipodystrophy syndromes in Spain
Fernández-Pombo et al.
Front Endocrinol (Lausanne)
DOI: 10.3389/fendo.2023.1250203.
https://pubmed.ncbi.nlm.nih.gov/38034001/